Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-18 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries. |
| 2019-04-12 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries. The depth and breadth of his financial experience support his continued service as a member of the Board. |
| 2020-04-15 | Mr. Hinrichs served as CFO of Cibus Ltd., Alere, Inc., CareFusion Corporation, and Cardinal Health; over 25 years of experience in financial and accounting matters. |
| 2021-04-05 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries... supports his continued service as a member of the Board. |
| 2022-04-04 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries. The depth and breadth of his financial experience support his continued service as a member of the Board. |
| 2023-04-10 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries... supports his continued service as a member of the Board. |
| 2024-04-08 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries... supports his continued service as a member of the Board. |
| 2025-04-07 | Mr. Hinrichs has over 25 years of experience in financial and accounting matters at companies in the medical device and pharmaceutical industries... The depth and breadth of his financial experience support his continued service as a member of the Board. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-30 | Mr. Hinrichs, 46, was appointed to the Board in April 2014. The Board believes that Mr. Hinrich's financial and accounting experience provide important expertise to the Board and will enable him to provide service and leadership as the Chair of the Company’s Audit and Finance Committee effective as of the Annual General Meeting. |
| 2015-04-30 | Mr. Hinrichs, 47, was appointed to the Board in April 2014. Since April 2015, he has served as Executive Vice President and Chief Financial Officer of Alere Inc, a publicly traded diagnostic company. From December 2010 through March 2015, he served as Chief Financial Officer of CareFusion Corporation, a publicly traded medical technology company, prior to its sale to Becton Dickinson. He previously served as CareFusion's Senior Vice President, Global Customer Support, from January 2010 to December 2010, and as its Senior Vice President, Controller, from January 2009 to January 2010. Prior to joining CareFusion when it was spun off from Cardinal Health, Inc., he worked since 2004 at Cardinal Health in various positions including Executive Vice President and Corporate Controller of Cardinal Health, and as Executive Vice President and Chief Financial Officer of its Healthcare Supply Chain Services segment. He joined Cardinal Health following over a decade of finance and marketing roles at Merck & Co. He holds undergraduate and graduate degrees in business from Carnegie Mellon University. |
| 2016-04-29 | Mr. Hinrichs, 48, was appointed to the Board in April 2014. He has served as Chair of the Audit and Finance Committee. ... The following table provides information regarding compensation to non-employee directors who served during the fiscal year ended December 31, 2015. James F. Hinrichs Fees Earned or Paid in Cash ($) 75,000, Restricted Stock Awards (Number of Shares Granted) 5,000, Grant Date Fair Value of Restricted Stock Awards ($) 165,600, Total ($) 240,600. |
| 2017-04-28 | Mr. Hinrichs, 49, was appointed to the Board in April 2014. ... Mr. Hinrichs serves as Chair of the Audit and Finance Committee, and is a member of the Compensation Committee and Nominating & Governance Committee. ... The following table provides information regarding the 2016 compensation of non-employee directors. James F. Hinrichs: Fees Earned or Paid in Cash ($) 75,000, Restricted Stock Awards (Number of Shares Granted) 3,950, Grant Date Fair Value of Restricted Stock Awards ($) 175,341, Total ($) 250,341. |
| 2019-04-29 | Mr. Hinrichs, 51, was appointed to the Board in April 2014. Since April 2018, he has served as Chief Financial Officer of Cibus, a privately-held agricultural biotech company. ... The Board believes that Mr. Hinrichs’ financial and accounting experience gained through the foregoing roles, including in particular his experience as a public company chief financial officer, provide important expertise to the Board and enable him to provide service and leadership as the Chair of the Company’s Audit and Finance Committee. ... James F. Hinrichs 75,000 fees earned or paid in cash, 2,900 restricted stock awards, 164,952 grant date fair value of restricted stock awards, total 239,952. |
| 2020-04-29 | Mr. Hinrichs, 52, was appointed to the Board in April 2014... The Board believes that Mr. Hinrichs’ financial and accounting experience provide important expertise to the Board and enable him to provide service and leadership as the Chair of the Company’s Audit and Finance Committee. ... The following table provides information regarding the 2019 compensation of non-employee directors. ... James F. Hinrichs 100,000 fees earned in cash, 3,431 restricted stock awards, 174,981 grant date fair value of restricted stock awards, total 274,981. |
| 2021-04-29 | James F. Hinrichs Mr. Hinrichs, 53, was appointed to the Board in April 2014. Mr. Hinrichs serves as Chair of the Audit and Finance Committee. The following table provides information regarding the 2020 compensation of non-employee directors. James F. Hinrichs Fees Earned or Paid in Cash: 82,167 Restricted Stock Unit Awards: 4,588 Grant Date Fair Value of Restricted Stock Awards: 175,032 Total: 257,199 |
| 2022-04-27 | Mr. Hinrichs, 54, was appointed to the Board in April 2014. He serves as Chair of the Audit and Finance Committee and is a member of the Compensation and Talent Development Committee. He received total compensation of $260,022 in 2021. |
| 2023-04-27 | James F. Hinrichs Independent Director Age 55 Audit & Finance Committee Chair Compensation and Talent Development Committee member 2022 compensation: $260,022 |
Data sourced from SEC filings. Last updated: 2026-02-03